Innovation and growth should drive several biotech and drug stocks higher in 2020, despite political risk around drug pricing, according to Mizuho.
"Overall, we are bullish on the biopharma sector mainly because of the remarkable innovation we are seeing, including in areas such as neuroscience where innovation has historically been tougher to come by," Mizuho said in a note to clients.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stock market day-trading strategy: Order flow and scalping with size - Business InsiderJosh Evans' cancer diagnosis motivated him to start trading stocks full time. He shares the changes in strategy that completely turned around his investing fortunes.
Source: BusinessInsider - 🏆 729. / 51 Read more »